RxDoctor Payments Data

Xiaoming Hester

Family · Yazoo City, MSNPI 1902575830

Payments from drug & device makers

$3,426in general payments, 2019–2025

Across 59 payments — averaging $58.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Mallinckrodt Hospital Products Inc.$346
  • AstraZeneca$315
  • GSK$231
  • Boehringer Ingelheim$193
  • Sanofi$165
  • plus $534 from 9 others

What the payments were for

  • Travel & lodging$1,32639%
  • Food & beverage$2,00058%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,426 in reported general payments places this provider in the 85th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$2,757
Medicare patients
24
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin45$35,957
EliquisApixaban29$19,648
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl80$13,326
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,044
LinzessLinaclotide18$10,579
JanuviaSitagliptin Phosphate12$9,092
Albuterol Sulfate HfaAlbuterol Sulfate64$1,940
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen130$1,806
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,308
Omeprazole93$1,243
Atorvastatin Calcium118$1,082
Gabapentin70$931
Amlodipine Besylate185$914
Colchicine19$847
Metformin Hcl122$759

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$193$35,95745 claims
GSKTrelegy Ellipta$231$11,04417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,007 family providers in Mississippi.

Other family in Yazoo City

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →